BRIEF published on 07/16/2025 at 08:05, 11 months 4 days ago GeNeuro SA announces the liquidation of its French subsidiary Restructuring Liquidation GeNeuro Subsidiary Neurodegenerative
PRESS RELEASE published on 07/16/2025 at 08:00, 11 months 4 days ago Inside Information / Other news releases GeNeuro SA announces the liquidation of its French subsidiary GeNeuro Innovation SAS, part of the restructuring process. Court appointed liquidator SELARL MJ-Synergie Liquidation Restructuring Process GeNeuro SA GeNeuro Innovation SAS SELARL MJ-Synergie
BRIEF published on 06/30/2025 at 19:42, 11 months 20 days ago GeNeuro's Shareholders Approve All Resolutions at Extraordinary General Meeting Shareholder Approval Restructuring Extraordinary General Meeting GeNeuro Asset Monetization
PRESS RELEASE published on 06/30/2025 at 19:37, 11 months 20 days ago Inside Information / Other news releases GeNeuro announces approval of all resolutions proposed at Extraordinary General Meeting with 69.1% share capital representation. Jesús Martin-Garcia named Executive Chairman Shareholders EGM Resolutions GeNeuro Jesús Martin-Garcia
BRIEF published on 06/12/2025 at 22:47, 1 year ago GeNeuro SA: Judicial recovery for its French subsidiary Restructuring GeNeuro SA Judicial Recovery French Subsidiary Judicial Administrator
PRESS RELEASE published on 06/12/2025 at 22:42, 1 year ago Inside Information / Other news releases GeNeuro SA's French subsidiary GeNeuro Innovation SAS enters receivership proceedings amidst parent company's debt-restructuring efforts Autoimmune Diseases GeNeuro SA Neurodegenerative Diseases Debt-restructuring Receivership Proceedings
BRIEF published on 12/13/2024 at 12:02, 1 year 6 months ago Citigroup reduces its stake in GENEURO SA Euronext Paris Sale Of Shares Threshold Crossing GeNeuro SA Citigroup
BRIEF published on 12/06/2024 at 18:35, 1 year 6 months ago GeNeuro's New Precision Medicine for ALS Unveiled Precision Medicine GeNeuro ALS Treatment GNK-301 HERV-K ENV
PRESS RELEASE published on 12/06/2024 at 18:30, 1 year 6 months ago Inside Information / Other news releases GeNeuro presents groundbreaking findings on precision medicine for ALS patients with GNK-301 at the 35th International Symposium on ALS/MND. Research highlights potential of targeting HERV-K ENV to transform ALS treatment Precision Medicine ALS GeNeuro GNK-301 HERV-K ENV
BRIEF published on 11/06/2024 at 09:48, 1 year 7 months ago Crossing of thresholds by Invus Public Equities in GENEURO SA Euronext Paris Capital Increase Crossing Thresholds GeNeuro SA Invus Public Equities
Published on 06/20/2026 at 01:00, 19 hours 54 minutes ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 20 hours 54 minutes ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 1 day 16 hours ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 1 day 19 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 1 day 19 hours ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/20/2026 at 06:00, 14 hours 54 minutes ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 1 day ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 19:01, 1 day 1 hour ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 19:33, 1 day 1 hour ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day 1 hour ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/18/2026 at 18:00, 2 days 2 hours ago Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 2 days 3 hours ago EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 2 days 3 hours ago Statement of transactions in own shares from June 8, 2026 to June 12, 2026
